Cargando…

Efficacy of EHL N9-GP for on-demand treatment of bleeding episodes in hemophilia B: analysis of pivotal trial data

Detalles Bibliográficos
Autores principales:	Escobar, Miguel A, Walsh, Christopher E, Cooper, David L, Young, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662862/ https://www.ncbi.nlm.nih.gov/pubmed/31413650 http://dx.doi.org/10.2147/JBM.S212690

Ejemplares similares

Prevention and Management of Bleeding Episodes in Children with Hemophilia
por: Ljung, Rolf C. R.
Publicado: (2018)

Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients
por: Chan, Anthony K., et al.
Publicado: (2020)

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A
por: Knöbl, Paul
Publicado: (2018)

An imprint method to produce surface asperities for EHL and RCF experiments
por: Everitt, Carl-Magnus, et al.
Publicado: (2020)

The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A
por: Male, Christoph, et al.
Publicado: (2022)

Extensor digitorum longus (EDL) to extensor hallucis longus (EHL) tendon transfer for delayed EHL tendon rupture following anterior ankle arthroscopy – Case report
por: Fallah, Jean-Michel, et al.
Publicado: (2023)

Developing a Short Assessment of Environmental Health Literacy (SA-EHL)
por: Rohlman, Diana, et al.
Publicado: (2022)

Protocol of the baseline assessment for the Environments for Healthy Living (EHL) Wales cohort study
por: Hill, Rebecca A, et al.
Publicado: (2010)

Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study
por: Ma, Alice D., et al.
Publicado: (2016)

Approaches to Improvement of Digital Health Literacy (eHL) in the Context of Person-Centered Care
por: Busse, Theresa Sophie, et al.
Publicado: (2022)

Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PARADIGM 2 Trials
por: Mancuso, Maria Elisa, et al.
Publicado: (2023)

An overview of the pathfinder clinical trials program: Long‐term efficacy and safety of N8‐GP in patients with hemophilia A
por: Matsushita, Tadashi, et al.
Publicado: (2020)

Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A
por: Pipe, Steven
Publicado: (2009)

Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A
por: Rossbach, Hans-Christoph
Publicado: (2010)

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India
por: Choraria, Nirmalkumar, et al.
Publicado: (2022)

Acquired Hemophilia A with Gastrointestinal Bleeding
por: Park, Narae, et al.
Publicado: (2020)

The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022)

Experimental Study on the Effect of Micro-Texture on EHL Point-Contact Film Thickness Subject to Sliding Conditions
por: Sun, Jianxin, et al.
Publicado: (2022)

Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India
por: Choraria, Nirmalkumar, et al.
Publicado: (2022)

EHLS at School: school-age follow-up of the Early Home Learning Study cluster randomized controlled trial
por: Westrupp, Elizabeth M., et al.
Publicado: (2018)

Predictive Modeling Identifies Total Bleeds at 12-Weeks Postswitch to N8-GP Prophylaxis as a Predictor of Treatment Response
por: Chowdary, Pratima, et al.
Publicado: (2021)

Long‐term safety and efficacy of N8‐GP in previously treated pediatric patients with hemophilia A: Final results from pathfinder5
por: Šaulytė Trakymienė, Sonata, et al.
Publicado: (2020)

Long‐term safety and efficacy of N8‐GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2
por: Giangrande, Paul, et al.
Publicado: (2020)

An Unusual Case of Bleeding: Acquired Hemophilia A
por: Jahangiri, Omeed S, et al.
Publicado: (2023)

Population Pharmacokinetic Modeling Of On-Demand And Surgical Use Of Nonacog Beta Pegol (N9-GP) And rFIXFc Based Upon The paradigm 7 Comparative Pharmacokinetic Study
por: Simpson, Mindy L, et al.
Publicado: (2019)

Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial
por: Wu, Runhui, et al.
Publicado: (2020)

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
por: O'Sullivan, Jamie M, et al.
Publicado: (2020)

Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
por: Escobar, Miguel A., et al.
Publicado: (2022)

Digital single-operator cholangioscopy with EHL as salvage therapy of an internalized and stone-impacted biliary stent 13 years after implantation
por: Loosen, Sven H., et al.
Publicado: (2022)

Perioperative Outcomes of Patients with Bleeding Disorders Undergoing Major Surgery at an Academic Hemophilia Treatment Center
por: Rhoades, Ruben, et al.
Publicado: (2023)

Illustrative Cases from the Pathfinder Clinical Trials of Patients with Hemophilia A Treated with Turoctocog Alfa Pegol (N8-GP)
por: Klamroth, Robert, et al.
Publicado: (2021)

Turoctocog alfa pegol (N8‐GP) in severe hemophilia A: Long‐term safety and efficacy in previously treated patients of all ages in the pathfinder8 study
por: Lentz, Steven R., et al.
Publicado: (2022)

Undiagnosed Acquired Hemophilia A: Presenting as Recurrent Gastrointestinal Bleeding
por: Roy, Arya Mariam, et al.
Publicado: (2020)

Acquired Hemophilia A: A Potentially Fatal Bleeding Disorder
por: Singh, Navdeep, et al.
Publicado: (2020)

Investigation of the Bleeding Tendency in Sudanese Female Carriers of Hemophilia B
por: Abker, Ismail Ali Abdallah, et al.
Publicado: (2022)

Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies
por: Marino, Renato
Publicado: (2023)

Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
por: Garcia, Jessica, et al.
Publicado: (2023)

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation
por: Grottke, Oliver, et al.
Publicado: (2023)

Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding model
por: Pittman, Debra D., et al.
Publicado: (2022)

Bleeding phenotype in nonsevere hemophilia by International Society on Thrombosis and Haemostasis bleeding assessment tool, bleeding frequency, and the joint status
por: Rejtő, Judit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_95fhhjou1lmonmtmdc27p9l3cs